Caxton Corporation’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $880K | Hold |
|
|||||
|
2022
Q2 | $736K | Hold |
|
|||||
|
2022
Q1 | $970K | Hold |
|
|||||
|
2021
Q4 | $607K | Sell |
|
|||||
|
2021
Q3 | $939K | Buy |
|
|||||
|
2021
Q2 | $1.18M | Buy |
|
|||||
|
2021
Q1 | $833K | Buy |
|
|||||
|
2020
Q4 | $972K | Sell |
|
|||||
|
2020
Q3 | $919K | Buy |
|
|||||
|
2020
Q2 | $787K | Buy |
|
|||||
|
2020
Q1 | $555K | Buy |
|
|||||
|
2019
Q4 | $925K | Buy |
|
|||||
|
2019
Q3 | $636K | Buy |
|
|||||
|
2019
Q2 | $656K | Buy |
|
|||||
|
2019
Q1 | $689K | Buy |
|
|||||
|
2018
Q4 | $444K | Buy |
|
|||||
|
2018
Q3 | $306K | Buy |
|